{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:50:58Z","timestamp":1791503458973,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005110","name":"Alfons and Gertrud Kassel Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.modpat.2026.101092","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:36:17Z","timestamp":1791214577000},"page":"101092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-Foundation-Model Ensemble Predicts Gene Expression in Muscle-Invasive Bladder Cancer for Patient Outcome Stratification"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6799-8504","authenticated-orcid":false,"given":"Ingvild Fr\u00f8berg","family":"Mathisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florestan J.","family":"Koll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin Sebastian","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel H.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fassl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"K\u00f6llermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Flinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2026.101092_bib1","unstructured":"World Bladder Cancer Patient Coalition. GLOBOCAN 2022: Bladder cancer 9th most common worldwide - World Bladder Cancer Patient Coalition. World Bladder Cancer Patient Coalition. Published February 22, 2024. https:\/\/worldbladdercancer.org\/news_events\/globocan-2022-bladder-cancer-is-the-9th-most-commonly-diagnosed-worldwide\/#:\u223c:text=data%20estimated%20that-,614%2C298%20people,-were%20diagnosed%20with"},{"issue":"4_suppl","key":"10.1016\/j.modpat.2026.101092_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1200\/JCO.2024.42.4_suppl.552","article-title":"Characteristics, treatment patterns, and clinical outcomes of patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer in the real world","volume":"42","author":"Squires","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","article-title":"Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants","volume":"75","author":"Warrick","year":"2018","journal-title":"European Urology"},{"issue":"16","key":"10.1016\/j.modpat.2026.101092_bib4","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-18-1106","article-title":"Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer","volume":"25","author":"Seiler","year":"2018","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1016\/j.modpat.2026.101092_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib6","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1038\/s41598-020-66747-7","article-title":"Assessment of luminal and basal phenotypes in bladder cancer","volume":"10","author":"Guo","year":"2020","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.modpat.2026.101092_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MOU.0000000000000641","article-title":"Clinical implications of molecular subtyping in bladder cancer","volume":"29","author":"Satyal","year":"2019","journal-title":"Current Opinion in Urology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib8","first-page":"jcp","article-title":"Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancer","volume":"78","author":"Koll","year":"2023","journal-title":"Journal of Clinical Pathology"},{"issue":"4","key":"10.1016\/j.modpat.2026.101092_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2019","journal-title":"European Urology"},{"issue":"7","key":"10.1016\/j.modpat.2026.101092_bib10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","article-title":"Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer","volume":"25","author":"Kather","year":"2019","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/j.modpat.2026.101092_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/path.5879","article-title":"Deep learning based on hematoxylin\u2013eosin staining outperforms immunohistochemistry in predicting molecular subtypes of gastric adenocarcinoma","volume":"257","author":"Flinner","year":"2022","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.modpat.2026.101092_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03780-x","article-title":"Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection","author":"Campanella","year":"2025","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/j.modpat.2026.101092_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.eururo.2020.04.023","article-title":"Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides","volume":"78","author":"Woerl","year":"2020","journal-title":"European Urology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41698-020-0120-3","article-title":"Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning","volume":"4","author":"Chen","year":"2020","journal-title":"Npj Precision Oncology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib15","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41467-020-17678-4","article-title":"A deep learning model to predict RNA-Seq expression of tumours from whole slide images","volume":"11","author":"Schmauch","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.modpat.2026.101092_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103388","article-title":"Deep learning predicts gene expression as an intermediate data modality to identify susceptibility patterns in Mycobacterium tuberculosis infected Diversity Outbred mice","volume":"67","author":"Tavolara","year":"2021","journal-title":"EBioMedicine"},{"issue":"19","key":"10.1016\/j.modpat.2026.101092_bib17","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1158\/0008-5472.CAN-21-0482","article-title":"Predicting Molecular Phenotypes from Histopathology Images: A Transcriptome-Wide Expression\u2013Morphology Analysis in Breast Cancer","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.modpat.2026.101092_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/diagnostics14050462","article-title":"Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma","volume":"14","author":"Murchan","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.modpat.2026.101092_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2022.102559","article-title":"Transformer-based unsupervised contrastive learning for histopathological image classification","volume":"81","author":"Wang","year":"2022","journal-title":"Medical Image Analysis"},{"issue":"10","key":"10.1016\/j.modpat.2026.101092_bib20","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1038\/s41591-024-03141-0","article-title":"A foundation model for clinical-grade computational pathology and rare cancers detection","volume":"30","author":"Vorontsov","year":"2024","journal-title":"Nature Medicine"},{"issue":"8015","key":"10.1016\/j.modpat.2026.101092_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41586-024-07441-w","article-title":"A whole-slide foundation model for digital pathology from real-world data","volume":"630","author":"Xu","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7529893","article-title":"Method for diagnosis of acute lymphoblastic leukemia based on VIT\u2010CNN Ensemble model","volume":"2021","author":"Jiang","year":"2021","journal-title":"Computational Intelligence and Neuroscience"},{"issue":"14","key":"10.1016\/j.modpat.2026.101092_bib23","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3390\/plants12142642","article-title":"Plant-CNN-ViT: Plant Classification with Ensemble of Convolutional Neural Networks and Vision Transformer","volume":"12","author":"Lee","year":"2023","journal-title":"Plants"},{"issue":"21","key":"10.1016\/j.modpat.2026.101092_bib24","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.3390\/rs15215208","article-title":"Vision Transformer-Based Ensemble Learning for hyperspectral image classification","volume":"15","author":"Liu","year":"2023","journal-title":"Remote Sensing"},{"issue":"3","key":"10.1016\/j.modpat.2026.101092_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of Muscle-Invasive Bladder Cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.modpat.2026.101092_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00292-024-01305-w","article-title":"Histomolekulare Klassifikation des Urothelkarzinoms der Harnblase","volume":"45","author":"Stoll","year":"2024","journal-title":"Die Pathologie"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12885-023-11016-9","article-title":"Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens","volume":"23","author":"Koll","year":"2023","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2026.101092_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajhg.2019.01.002","article-title":"ACAT: A Fast and Powerful p Value Combination Method for Rare-Variant Analysis in Sequencing Studies","volume":"104","author":"Liu","year":"2019","journal-title":"The American Journal of Human Genetics"},{"issue":"4","key":"10.1016\/j.modpat.2026.101092_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.eururo.2023.03.020","article-title":"Molecular urothelial tumor cell subtypes remain stable during metastatic evolution","volume":"85","author":"Cox","year":"2023","journal-title":"European Urology"},{"issue":"20","key":"10.1016\/j.modpat.2026.101092_bib30","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1200\/JCO.23.01983","article-title":"NECTIN4 amplification is frequent in solid tumors and predicts enfortumab vedotin response in metastatic urothelial cancer","volume":"42","author":"Kl\u00fcmper","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/j.modpat.2026.101092_bib31","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.euo.2021.11.005","article-title":"TROP2 expression across molecular subtypes of urothelial carcinoma and enfortumab vedotin-resistant cells","volume":"5","author":"Chou","year":"2022","journal-title":"European Urology Oncology"},{"issue":"6","key":"10.1016\/j.modpat.2026.101092_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.urolonc.2026.111095","article-title":"Concordance and prognostic value of antibody drug conjugate and checkpoint inhibition targets in matched bladder cancer specimens from transurethral resection of the bladder, radical cystectomy and lymphadenectomy","volume":"44","author":"Uysal","year":"2026","journal-title":"Urologic Oncology Seminars and Original Investigations"},{"key":"10.1016\/j.modpat.2026.101092_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejca.2021.01.036","article-title":"Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy","volume":"148","author":"Groeneveld","year":"2021","journal-title":"European Journal of Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12672-024-00982-6","article-title":"CXCL10 could be a prognostic and immunological biomarker in bladder cancer","volume":"15","author":"Yin","year":"2024","journal-title":"Discover Oncology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41598-021-04678-7","article-title":"Upregulation of IFN\u0263-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma","volume":"12","author":"Olkhov-Mitsel","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.modpat.2026.101092_bib36","first-page":"1","article-title":"Artificial intelligence meets whole slide images: deep learning model shapes an Immune-Hot tumor and guides precision therapy in bladder cancer","volume":"2022","author":"Jiang","year":"2022","journal-title":"Journal of Oncology"},{"issue":"3","key":"10.1016\/j.modpat.2026.101092_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejso.2011.01.004","article-title":"Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis","volume":"37","author":"Yang","year":"2011","journal-title":"European Journal of Surgical Oncology"},{"issue":"8","key":"10.1016\/j.modpat.2026.101092_bib38","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.urolonc.2012.06.011","article-title":"Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy","volume":"31","author":"Rink","year":"2012","journal-title":"Urologic Oncology Seminars and Original Investigations"},{"issue":"11","key":"10.1016\/j.modpat.2026.101092_bib39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1440-1827.2010.02592.x","article-title":"Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression","volume":"60","author":"Hagikura","year":"2010","journal-title":"Pathology International"},{"issue":"6","key":"10.1016\/j.modpat.2026.101092_bib40","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/cancers16061195","article-title":"CD44 in bladder cancer","volume":"16","author":"Duex","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib41","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1038\/s41467-022-34251-3","article-title":"FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation","volume":"13","author":"Warrick","year":"2022","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12885-019-5426-6","article-title":"PPAR\u03b3 activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway","volume":"19","author":"Lv","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41388-023-02876-3","article-title":"The urothelial gene regulatory network: understanding biology to improve bladder cancer management","volume":"43","author":"Ramal","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1555","article-title":"Snai2\u2010mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB","volume":"14","author":"Jiang","year":"2024","journal-title":"Clinical and Translational Medicine"},{"issue":"40","key":"10.1016\/j.modpat.2026.101092_bib45","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1038\/s41388-021-01957-5","article-title":"FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC\/STAT3 signaling axis in ovarian cancer","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.modpat.2026.101092_bib46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/j.modpat.2026.101092_bib47","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ajpath.2011.10.021","article-title":"FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of Castration-Resistant prostate cancer","volume":"180","author":"Gerhardt","year":"2011","journal-title":"American Journal of Pathology"},{"issue":"5","key":"10.1016\/j.modpat.2026.101092_bib48","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ajpath.2015.01.014","article-title":"Loss of FOXA1 drives sexually dimorphic changes in urothelial differentiation and is an independent predictor of poor prognosis in bladder cancer","volume":"185","author":"Reddy","year":"2015","journal-title":"American Journal of Pathology"},{"issue":"4","key":"10.1016\/j.modpat.2026.101092_bib49","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/jcm9040994","article-title":"FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy","volume":"9","author":"Sikic","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"4","key":"10.1016\/j.modpat.2026.101092_bib50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/sim.6370","article-title":"Comparing two correlated C indices with right\u2010censored survival outcome: a one\u2010shot nonparametric approach","volume":"34","author":"Kang","year":"2014","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.modpat.2026.101092_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01516-3","article-title":"Benchmarking foundation models as feature extractors for weakly supervised computational pathology","author":"Neidlinger","year":"2025","journal-title":"Nature Biomedical Engineering"},{"key":"10.1016\/j.modpat.2026.101092_bib52","unstructured":"Ali KM, Pazzani MJ. On the link between error correlation and error reduction in decision tree ensembles. Published 1995. https:\/\/escholarship.org\/uc\/item\/9k55v622"},{"issue":"3-4","key":"10.1016\/j.modpat.2026.101092_bib53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/095400996116820","article-title":"Ensemble learning using decorrelated neural networks","volume":"8","author":"Rosen","year":"1996","journal-title":"Connection Science"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JCO.23.02005","article-title":"Efficacy and safety of trastuzumab deruxtecan in patients with HER2-Expressing solid tumors: Primary results from the DESTINY-PanTumor02 Phase II trial","volume":"42","author":"Meric-Bernstam","year":"2023","journal-title":"Journal of Clinical Oncology"},{"issue":"23","key":"10.1016\/j.modpat.2026.101092_bib55","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.3390\/cancers14235807","article-title":"Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides","volume":"14","author":"Zheng","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib56","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1038\/s41467-024-54182-5","article-title":"Digital profiling of gene expression from histology images with linearized attention","volume":"15","author":"Pizurica","year":"2024","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib57","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41467-025-56618-y","article-title":"Benchmarking the translational potential of spatial gene expression prediction from histology","volume":"16","author":"Wang","year":"2025","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib58","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6042-1","article-title":"Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification","volume":"19","author":"Yuk","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.modpat.2026.101092_bib59","article-title":"Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma","volume":"10","author":"Zhang","year":"2022","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"6","key":"10.1016\/j.modpat.2026.101092_bib60","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/iub.2254","article-title":"SWI\/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer","volume":"72","author":"Stachowiak","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.modpat.2026.101092_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105801","article-title":"High-resolution transcriptome atlas of bladder cancer highlights the functional myeloid subsets in modulating immune microenvironment","volume":"117","author":"Liu","year":"2025","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.modpat.2026.101092_bib62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/CBM-190013","article-title":"E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma","volume":"25","author":"Gondkar","year":"2019","journal-title":"Cancer Biomarkers"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166271","article-title":"WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma","volume":"1868","author":"Na","year":"2021","journal-title":"Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"2","key":"10.1016\/j.modpat.2026.101092_bib64","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ydbio.2013.12.028","article-title":"Identification of ELF3 as an early transcriptional regulator of human urothelium","volume":"386","author":"B\u00f6ck","year":"2013","journal-title":"Developmental Biology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11652-0","article-title":"Blocking YAP1\u2013Liprin-\u03b22 interaction impedes metastasis and promotes tumor suppression in head and neck squamous carcinoma","volume":"15","author":"Woo","year":"2025","journal-title":"Scientific Reports"},{"key":"10.1016\/j.modpat.2026.101092_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.694777","article-title":"Identification of signature genes associated with invasiveness and the construction of a prognostic model that predicts the overall survival of bladder cancer","volume":"12","author":"He","year":"2021","journal-title":"Frontiers in Genetics"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/02611929221148447","article-title":"In Silico Prediction of Human Clinical Pharmacokinetics with ANDROMEDA by Prosilico: Predictions for an Established Benchmarking Data Set, a Modern Small Drug Data Set, and a Comparison with Laboratory Methods","volume":"51","author":"Fagerholm","year":"2022","journal-title":"Alternatives to Laboratory Animals"},{"issue":"6","key":"10.1016\/j.modpat.2026.101092_bib68","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41551-025-01495-5","article-title":"Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response","volume":"10","author":"Zhang","year":"2025","journal-title":"Nature Biomedical Engineering"},{"issue":"1","key":"10.1016\/j.modpat.2026.101092_bib69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41379-021-00911-w","article-title":"Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer","volume":"35","author":"Farahmand","year":"2021","journal-title":"Modern Pathology"},{"issue":"6","key":"10.1016\/j.modpat.2026.101092_bib70","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ajcp\/aqw064","article-title":"Using machine learning to predict laboratory test results","volume":"145","author":"Luo","year":"2016","journal-title":"American Journal of Clinical Pathology"},{"issue":"3","key":"10.1016\/j.modpat.2026.101092_bib71","doi-asserted-by":"crossref","DOI":"10.2196\/16374","article-title":"Learning latent space representations to predict patient outcomes: model development and validation","volume":"22","author":"Rongali","year":"2020","journal-title":"Journal of Medical Internet Research"},{"issue":"3","key":"10.1016\/j.modpat.2026.101092_bib72","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2019-319866","article-title":"Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning","volume":"70","author":"Sirinukunwattana","year":"2020","journal-title":"Gut"},{"issue":"14","key":"10.1016\/j.modpat.2026.101092_bib73","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1873-3468.14898","article-title":"Living in a noisy world\u2014origins of gene expression noise and its impact on cellular decision\u2010making","volume":"598","author":"Pal","year":"2024","journal-title":"FEBS Letters"},{"key":"10.1016\/j.modpat.2026.101092_bib74","article-title":"HISTOGWAS: an AI-enabled framework for automated genetic analysis of tissue phenotypes in histology cohorts","author":"Chaudhary","year":"2024","journal-title":"bioRxiv (Cold Spring Harbor Laboratory)"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:16:30Z","timestamp":1791501390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226001353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":74,"alternative-id":["S0893395226001353"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101092","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-Foundation-Model Ensemble Predicts Gene Expression in Muscle-Invasive Bladder Cancer for Patient Outcome Stratification","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101092"}}